NO20033828L - Peptiddeformylaseinhibitorer - Google Patents
PeptiddeformylaseinhibitorerInfo
- Publication number
- NO20033828L NO20033828L NO20033828A NO20033828A NO20033828L NO 20033828 L NO20033828 L NO 20033828L NO 20033828 A NO20033828 A NO 20033828A NO 20033828 A NO20033828 A NO 20033828A NO 20033828 L NO20033828 L NO 20033828L
- Authority
- NO
- Norway
- Prior art keywords
- peptiddeformylaseinhibitorer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/34—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a carbon skeleton further substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/30—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
- C07C243/32—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/02—Compounds containing any of the groups, e.g. carbazates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/06—Compounds containing any of the groups, e.g. semicarbazides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrrole Compounds (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27257001P | 2001-03-01 | 2001-03-01 | |
| PCT/US2002/006275 WO2002070541A2 (fr) | 2001-03-01 | 2002-03-01 | Inhibiteurs de la peptide deformylase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20033828D0 NO20033828D0 (no) | 2003-08-28 |
| NO20033828L true NO20033828L (no) | 2003-10-06 |
Family
ID=23040368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20033828A NO20033828L (no) | 2001-03-01 | 2003-08-28 | Peptiddeformylaseinhibitorer |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7019003B2 (fr) |
| EP (1) | EP1363873B1 (fr) |
| JP (1) | JP4266638B2 (fr) |
| KR (1) | KR20030092008A (fr) |
| CN (1) | CN1505607A (fr) |
| AR (1) | AR032920A1 (fr) |
| AU (1) | AU2002335490B2 (fr) |
| BR (1) | BR0207810A (fr) |
| CA (1) | CA2439827A1 (fr) |
| CZ (1) | CZ20032342A3 (fr) |
| EG (1) | EG24516A (fr) |
| HU (1) | HUP0303308A2 (fr) |
| IL (1) | IL157643A0 (fr) |
| MX (1) | MXPA03007869A (fr) |
| NO (1) | NO20033828L (fr) |
| NZ (1) | NZ527728A (fr) |
| PE (1) | PE20020906A1 (fr) |
| PL (1) | PL364563A1 (fr) |
| UY (1) | UY27192A1 (fr) |
| WO (1) | WO2002070541A2 (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY27813A1 (es) | 2002-05-31 | 2003-12-31 | Smithkline Beecham Corp | Inhibidores de la peptido-desformilasa |
| JP2005532358A (ja) * | 2002-06-06 | 2005-10-27 | スミスクライン・ビーチャム・コーポレイション | ペプチドデホルミラーゼ阻害剤 |
| ES2321504T3 (es) * | 2002-09-19 | 2009-06-08 | Novartis Ag | Proceso para la preparacion de productos intermedios. |
| GB0229673D0 (en) * | 2002-12-19 | 2003-01-29 | British Biotech Pharm | Antibacterial agents |
| US7332485B2 (en) * | 2003-07-08 | 2008-02-19 | Smithkline Beecham Corp | Peptide deformylase inhibitors |
| EP1654239A4 (fr) * | 2003-08-15 | 2008-10-01 | Smithkline Beecham Corp | Inhibiteurs de la deformylase de peptides |
| WO2006055663A2 (fr) | 2004-11-17 | 2006-05-26 | Smithkline Beecham Corporation | Nouvelle utilisation |
| US7982053B2 (en) * | 2005-07-29 | 2011-07-19 | Glaxosmithkline Llc | Peptide deformylase inhibitors |
| US7622492B2 (en) | 2005-08-31 | 2009-11-24 | Hoffmann-La Roche Inc. | Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase |
| WO2007081597A2 (fr) * | 2005-10-21 | 2007-07-19 | Glaxo Group Limited | Composés |
| KR100753796B1 (ko) * | 2006-07-28 | 2007-08-31 | 주식회사 프로메디텍 | 데포르밀라제 저해제, 이의 제조방법, 및 이를 포함하는조성물 |
| GB0707706D0 (en) * | 2007-04-20 | 2007-05-30 | Glaxo Group Ltd | Compounds |
| UA108596C2 (xx) * | 2007-11-09 | 2015-05-25 | Інгібітори пептиддеформілази | |
| CA2710039C (fr) | 2007-12-26 | 2018-07-03 | Critical Outcome Technologies, Inc. | Semicarbazones, thiosemicarnazones et composes associes, et methodes de traitement du cancer |
| EP2318406B1 (fr) | 2008-07-17 | 2016-01-27 | Critical Outcome Technologies, Inc. | Composés inhibiteurs et procédés de traitement du cancer |
| CA2999435A1 (fr) | 2010-04-01 | 2011-10-06 | Critical Outcome Technologies Inc. | Composes et methodes pour le traitement du vih |
| JP2015500238A (ja) * | 2011-12-02 | 2015-01-05 | グラクソスミスクライン、インテレクチュアル、プロパティー、ナンバー2、リミテッドGlaxosmithkline Intellectual Property No.2 Limited | ペプチドデホルミラーゼ阻害剤 |
| CN116375698B (zh) * | 2023-06-05 | 2023-08-01 | 中国林业科学研究院林产化学工业研究所 | 具有靶向抗肿瘤活性的漆酚基异羟肟酸型hdac抑制剂及其制备方法和应用 |
| CN119462779A (zh) * | 2024-11-06 | 2025-02-18 | 中国船舶集团有限公司第七一八研究所 | 一种光引发剂fmt的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK77487A (da) | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | Hydroxylaminderivater |
| GB9223904D0 (en) * | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
| US6013792A (en) | 1993-08-05 | 2000-01-11 | Syntex (U.S.A.), Inc. | Matrix metalloprotease inhibitors |
| US6037472A (en) * | 1993-11-04 | 2000-03-14 | Syntex (U.S.A.) Inc. | Matrix metalloprotease inhibitors |
| JPH10500986A (ja) | 1994-05-28 | 1998-01-27 | ブリテッシュ バイオテック ファーマシューティカルズ リミテッド | 金属タンパク質分解酵素阻害剤 |
| GB9827805D0 (en) * | 1998-12-16 | 1999-02-10 | British Biotech Pharm | Antibacterial agents |
| WO2001042431A2 (fr) | 1999-12-08 | 2001-06-14 | Bayer Aktiengesellschaft | Regulation de la deformylase des mitochondries humaines |
-
2002
- 2002-02-28 AR ARP020100730A patent/AR032920A1/es not_active Application Discontinuation
- 2002-02-28 UY UY27192A patent/UY27192A1/es not_active Application Discontinuation
- 2002-03-01 PE PE2002000170A patent/PE20020906A1/es not_active Application Discontinuation
- 2002-03-01 IL IL15764302A patent/IL157643A0/xx unknown
- 2002-03-01 MX MXPA03007869A patent/MXPA03007869A/es not_active Application Discontinuation
- 2002-03-01 JP JP2002569860A patent/JP4266638B2/ja not_active Expired - Fee Related
- 2002-03-01 CN CNA028092570A patent/CN1505607A/zh active Pending
- 2002-03-01 US US10/469,433 patent/US7019003B2/en not_active Expired - Fee Related
- 2002-03-01 CZ CZ20032342A patent/CZ20032342A3/cs unknown
- 2002-03-01 AU AU2002335490A patent/AU2002335490B2/en not_active Ceased
- 2002-03-01 CA CA002439827A patent/CA2439827A1/fr not_active Abandoned
- 2002-03-01 WO PCT/US2002/006275 patent/WO2002070541A2/fr not_active Ceased
- 2002-03-01 HU HU0303308A patent/HUP0303308A2/hu unknown
- 2002-03-01 NZ NZ527728A patent/NZ527728A/en not_active IP Right Cessation
- 2002-03-01 BR BRPI0207810-4A patent/BR0207810A/pt not_active IP Right Cessation
- 2002-03-01 PL PL02364563A patent/PL364563A1/xx not_active Application Discontinuation
- 2002-03-01 EP EP02748375.9A patent/EP1363873B1/fr not_active Expired - Lifetime
- 2002-03-01 KR KR10-2003-7011370A patent/KR20030092008A/ko not_active Ceased
-
2003
- 2003-05-20 EG EG2003050473A patent/EG24516A/xx active
- 2003-08-28 NO NO20033828A patent/NO20033828L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4266638B2 (ja) | 2009-05-20 |
| AR032920A1 (es) | 2003-12-03 |
| AU2002335490B2 (en) | 2005-10-20 |
| KR20030092008A (ko) | 2003-12-03 |
| US20040087585A1 (en) | 2004-05-06 |
| NO20033828D0 (no) | 2003-08-28 |
| EP1363873A4 (fr) | 2006-01-04 |
| EP1363873B1 (fr) | 2016-04-20 |
| WO2002070541A3 (fr) | 2002-12-19 |
| HUP0303308A2 (hu) | 2004-01-28 |
| EP1363873A2 (fr) | 2003-11-26 |
| UY27192A1 (es) | 2002-09-30 |
| CZ20032342A3 (cs) | 2004-04-14 |
| EG24516A (en) | 2009-08-19 |
| BR0207810A (pt) | 2008-04-15 |
| MXPA03007869A (es) | 2003-12-04 |
| PE20020906A1 (es) | 2002-12-08 |
| US7019003B2 (en) | 2006-03-28 |
| NZ527728A (en) | 2004-09-24 |
| CN1505607A (zh) | 2004-06-16 |
| JP2004537507A (ja) | 2004-12-16 |
| WO2002070541A2 (fr) | 2002-09-12 |
| CA2439827A1 (fr) | 2002-09-12 |
| IL157643A0 (en) | 2004-03-28 |
| PL364563A1 (en) | 2004-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50204184D1 (de) | Espressobrüheinrichtung | |
| ATE524462T1 (de) | C5-modifizierte indazolylpyrrolotriazine | |
| DE50214313D1 (de) | Koaxialmagentventil | |
| DE50208022D1 (de) | Wischblatt | |
| DE50212173D1 (de) | sgängern | |
| DE50206021D1 (de) | Schlauchklemme | |
| DE50204386D1 (de) | Kreuztransducer | |
| DE50209238D1 (de) | Kugelgelenk | |
| DE50204551D1 (de) | Kugelgelenk | |
| ATE335486T1 (de) | Hydrazono-malonitrile | |
| DE50211604D1 (de) | Chlag | |
| DE50209410D1 (de) | Kugelgelenk | |
| NO20033828D0 (no) | Peptiddeformylaseinhibitorer | |
| DE50208372D1 (de) | Schrankaufhängevorrichtung | |
| DE50204794D1 (de) | Kugelgelenk | |
| DE50211290D1 (de) | Handzange | |
| DE50203984D1 (de) | Kugelgelenk | |
| DE50203412D1 (de) | Schwenkkolbenverdränger | |
| DE50208029D1 (de) | Kugelgelenk | |
| ATE355059T1 (de) | Isoxazolopyridinone | |
| DE50201862D1 (de) | Messwandler | |
| DE50203093D1 (de) | Losradlager | |
| ATA18372001A (de) | Gelenksbolzenbaueinheit | |
| ATE319694T1 (de) | Phenylalkyne | |
| DE50209293D1 (de) | Amidpolymermasse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |